Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 08 Jun 2023

Administration of protopine prevents mitophagy and acute lung injury in sepsis

in Inflammation Pharmacology

Zhong Xiao
Juan Long
Jie Zhang
Zhimin Qiu
Chen Zhang
Hongbing Liu
Xinyong Liu
Kang Wang
Yahui Tang
Longwang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1104185

3,937 views
13 citations

Original Research

Published on 08 Jun 2023

Metformin alleviates lung-endothelial hyperpermeability by regulating cofilin-1/PP2AC pathway

in Inflammation Pharmacology

M. Rizwan Siddiqui
Narsa M. Reddy
Hafeez M. Faridi
Mohd Shahid
Thomas P. Shanley

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1211460

2,548 views
4 citations

Review

Published on 08 Jun 2023

Role of heparanase in ARDS through autophagy and exosome pathway (review)

in Inflammation Pharmacology

Fei Feng
Lin-Jun Wang
Jian-Chun Li
Ting-Ting Chen
Liping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1200782

3,287 views
3 citations

Systematic Review

Published on 07 Jun 2023

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis

in Inflammation Pharmacology

Juqi Zhang
Wenhui Li
Mingli Gong
Yanlun Gu
Hanxu Zhang
Bingqi Dong
Qi Guo
Xiaocong Pang
Qian Xiang
Xu He

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189389

8,090 views
20 citations

Editorial

Published on 05 Jun 2023

Editorial: Insights in inflammation pharmacology: 2022

in Inflammation Pharmacology

Paola Patrignani
Patrizia Ballerini
Per-Johan Jakobsson
Dieter Steinhilber

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1223761

1,369 views

Review

Published on 02 Jun 2023

Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

in Inflammation Pharmacology

Daniela Melchiorri
Sara Merlo
Benjamin Micallef
John-Joseph Borg
František Dráfi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1196413

17,344 views
31 citations

Original Research

Published on 01 Jun 2023

The elucidation of the anti-inflammatory mechanism of EMO in rheumatoid arthritis through an integrative approach combining bioinformatics and experimental verification

in Inflammation Pharmacology

Pusheng Hui
Sicong Zhou
Chunhao Cao
Wenting Zhao
Li Zeng
Xiaofeng Rong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1195567

5,123 views
5 citations

Review

Published on 01 Jun 2023

Natural flavones from edible and medicinal plants exhibit enormous potential to treat ulcerative colitis

in Inflammation Pharmacology

Qiang Lu
Yuhong Xie
Jingbin Luo
Qihai Gong
Cailan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1168990

4,325 views
15 citations

Review

Published on 01 Jun 2023

Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?

in Inflammation Pharmacology

Jing Ren
Huimin Li
Guixing Zeng
Boxian Pang
Qiuhong Wang
Junping Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1178596

8,455 views
24 citations

Correction

Published on 30 May 2023

Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis

in Inflammation Pharmacology

Franziska Elena Herrmann
Christian Hesslinger
Lutz Wollin
Peter Nickolaus

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219760

3,178 views
3 citations

Review

Published on 30 May 2023

Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with de novo intestinal bowel disease in multiple sclerosis: a review

in Inflammation Pharmacology

A. Quesada-Simó
A. Garrido-Marín
P. Nos
S. Gil-Perotín

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1186016

5,138 views
10 citations

Correction

Published on 25 May 2023

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy

in Inflammation Pharmacology

Xing Wang
Guobing Yin
Wei Zhang
Kunling Song
Longbin Zhang
Zufeng Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1220144

1,180 views

Editorial

Published on 19 May 2023

Editorial: Pathogenesis of diabetic foot ulcers

in Inflammation Pharmacology

Zhihong Peng
Jean-Philippe Lavigne

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218201

3,883 views
5 citations

Clinical Trial

Published on 17 May 2023

A randomized, double-blind pilot study of analgesic and anti-inflammatory effects of naproxen sodium and acetaminophen following dental implant placement surgery

in Inflammation Pharmacology

Katherine N. Theken
Mengxiang Chen
D. Lucas Wall
Truongan Pham
Stacey A. Secreto
Thomas H. Yoo
Allison N. Rascon
Yu-Cheng Chang
Jonathan M. Korostoff
Claire H. Mitchell

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199580

4,266 views
2 citations

Original Research

Published on 15 May 2023

TRAF-STOP alleviates osteoclastogenesis in periodontitis

in Inflammation Pharmacology

Yaxian Huang
Jinyan Wu
Chi Zhan
Rong Liu
Zhaocai Zhou
Xin Huang
Yaguang Tian
Zhengmei Lin
Zhi Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1119847

3,743 views
2 citations

Original Research

Published on 12 May 2023

PTPN2 targets TAK1 for dephosphorylation to improve cellular senescence and promote adipose tissue browning in T2DM

in Inflammation Pharmacology

Yapeng Liu
Lu Han
Ping Zhu
Ming Song
Yaoyuan Zhang
Linlin Meng
Wei Zhang
Cheng Zhang
Ming Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1124633

3,062 views
2 citations